Top upgrades and downgrades on 4/28

Analysts Notebookwrote a column04/28/2022 19:25

Upgrades

• $Acutus Medical(AFIB.US)$ : BTIG Upgrades to Buy from Neutral - PT $2

• $Antero Midstream(AM.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $13 (from $12)

• $Autohome(ATHM.US)$ : Citigroup Upgrades to Buy from Neutral - PT $30

• $Fifth Third Bancorp(FITB.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $52

•$Kinder Morgan(KMI.US)$ : Wells Fargo Upgrades to Equal Weight from Underweight - PT $21

• $MSCI Inc(MSCI.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $515

• $MaxLinear(MXL.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $66

• $RPC Inc(RES.US)$ : Johnson Rice Upgrades to Accumulate from Hold - PT $13 (from $12)

• $Teladoc Health(TDOC.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $66

• $Westinghouse Air Brake Technologies(WAB.US)$ : Wolfe Research Upgrades to Peerperform from Underperform

• $WR Berkley(WRB.US)$ : CFRA Upgrades to Buy From Hold

Downgrades

• $Greenhill(GHL.US)$ : KBW Downgrades to Underperform From Market Perform - PT $12 (From $16.50)

• $Coca-Cola(KO.US)$ : DZ Bank Downgrades to Hold from Buy - PT $69

• $Moelis & Co(MC.US)$ : Piper Sandler Downgrades to Neutral From Overweight - PT $50 (From $52)

• PEBO: Raymond James Downgrades to Market Perform from Outperform

• SIOX: Cantor Fitzgerald Downgrades to Neutral from Overweight - PT $0.80

• $Spotify Technology(SPOT.US)$ : Pivotal Research Downgrades to Hold from Buy - PT $110 (From $235)

• $Teladoc Health(TDOC.US)$ : Citigroup Downgrades to Neutral from Buy - PT $43

• $Teladoc Health(TDOC.US)$ : Credit Suisse Downgrades to Neutral From Outperform - PT $35 (From $114)

• $Vroom(VRM.US)$ : William Blair Downgrades to Market Perform from Outperform

Coverage initiated

• $Archer Aviation(ACHR.US)$ : JPMorgan initiates at Overweight - PT $7

• $Allstate(ALL.US)$ : Credit Suisse initiates at Outperform - PT $188

• $Arvinas(ARVN.US)$ : Credit Suisse initiates at Outperform - PT $104

•$AvidXchange(AVDX.US)$ : Morgan Stanley initiates at Equalweight - PT $9

• $Babylon Holdings(BBLN.US)$ : Berenberg initiates at Hold - PT $5

• $Beam Therapeutics(BEAM.US)$ : Credit Suisse initiates at Neutral - PT $62

• $C4 Therapeutics(CCCC.US)$ : Credit Suisse initiates at Underperform - PT $10

• $CRISPR Therapeutics(CRSP.US)$ : Credit Suisse initiates at Neutral - PT $78

• $EVgo Inc(EVGO.US)$ : Cantor Fitzgerald initiates at Overweight - PT $14

• $Homology Medicines(FIXX.US)$ : Credit Suisse initiates at Neutral - PT $2.70

• $Freshpet(FRPT.US)$ : Benchmark initiates at Buy - PT $135

• $Monte Rosa Therapeutics(GLUE.US)$ : Credit Suisse initiates at Neutral - PT $19

• $Joby Aviation(JOBY.US)$ : JPMorgan initiates at Neutral - PT $7

• $Kemper(KMPR.US)$ : Credit Suisse initiates at Underperform - PT $44

• $Kinetik Holdings(KNTK.US)$ : BofA Securities initiates at Buy - PT $80

• $Kymera Therapeutics(KYMR.US)$ : Credit Suisse initiates at Outperform - PT $63

• $Lilium(LILM.US)$ : JPMorgan initiates at Neutral - PT $5

• $Intellia Therapeutics(NTLA.US)$ : Credit Suisse initiates at Outperform - PT $100

• $Progressive(PGR.US)$ : Credit Suisse initiates at Neutral - PT $124

• $Privia Health(PRVA.US)$ : BTIG initiates at Buy - PT $35

Moomoo is an app offered by Moomoo Technologies Inc. that provides information about investments. Moomoo Technologies is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of Moomoo Technologies, its affiliates, or any employees of Moomoo Technologies or its affiliates. You are advised to consult a qualified financial or tax advisor for your personal financial planning and tax situations. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

274K Views

Comment

Report

Analysts Notebook

Posts 581Followers9851

Comment